RecruitingNot ApplicableNCT05783466

Dairy Lipids and Cardiometabolic Risk

Bioactive Dairy Lipids to Manage Cardiometabolic Risk in Obesity


Sponsor

Hospices Civils de Lyon

Enrollment

75 participants

Start Date

Jun 28, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

It is a randomized parallel arm intervention study in adults with severe obesity. The objective is to demonstrate that within a dietary handling for weight loss, the daily ingestion during 3 months of whole dairy products enriched with milk polar lipids or whole dairy products decreases to a greater extent fasting plasma apolipoprotein B concentrations than the daily ingestion of low-fat dairy products (control group). Metabolic parameters will be assessed before and after the 3-month intervention, both at fasting and in postprandial period after the consumption of standardized meals.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Low-fat dairy products, Milk polar lipid enriched whole-fat dairy products, and others for people with morbid obesity. The study is currently recruiting participants at 2 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERLow-fat dairy products

3-month intervention

OTHERWhole-fat dairy products

3-month intervention

OTHERMilk polar lipid enriched whole-fat dairy products

3-month intervention


Locations(2)

Centre de Recherche en Nutrition Humaine Rhône-Alpes

Pierre-Bénite, France

Centres Hospitalier Lyon Sud, Service d'Endocrinologie-Diabète-Nutrition

Pierre-Bénite, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05783466


Related Trials